Michael Otto on using probiotics to reduce Staphylococcus aureus

from The Lancet Microbe in conversation with · host The Lancet Microbe

Rebecca Barksby of The Lancet Microbe talks to Dr Michael Otto and his and his collaborators’ placebo-controlled phase 2 trial that used the probiotic Bacillus subtilis to reduce Staphylococcus aureus in adults who were colonised by the bacteria in the Songkhla region of Thailand. Read the full article: Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Episode metadata supplied by the publisher feed · Published Jan 13, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Michael Otto on using probiotics to reduce Staphylococcus aureus

0:00 20:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Lancet Microbe in conversation with?

This episode is 20 minutes long.

When was this The Lancet Microbe in conversation with episode published?

This episode was published on January 13, 2023.

Can I download this The Lancet Microbe in conversation with episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!